Penetration of interleukin-6 across the murine blood-brain barrier.
Interleukin-6 (IL-6) can alter brain function after peripheral administration, suggesting that it, like IL-1 alpha, IL-1 beta and TNF-alpha, might be able to cross the blood-brain barrier (BBB). We used multiple-time regression analysis to measure the unidirectional influx constant (Ki) into brain of radioactively labeled murine and human IL-6 given i.v. Ki values ranged from 3.05 to 4.54 (10(-4)) ml/g/min and were inhibited by unlabeled IL-6 but not IL-1 alpha or TNF-alpha, showing that the transport system for IL-6 is distinct from those for IL-1 alpha and TNF-alpha. Approximately 0.2% of the dose injected i.v. entered each gram of brain. The capillary depletion method showed that most of the IL-6 taken up by brain entered the parenchyma. However, only approximately 16% of the radioactivity recovered eluted as intact I-IL-6 in brain and approximately 50% in CSF after chromatographic separation by HPLC/Sephadex. The efflux rate for IL-6 injected into the lateral ventricle of the brain suggests that it enters the blood with the reabsorption of CSF. These results suggest that blood-borne IL-6 can reach sites behind the BBB, but that susceptibility to enzymatic degradation may limit contact time within the CNS.
Veterans Affairs Medical Center, New Orleans, LA 70146.
W A
WA
Banks
A J
AJ
Kastin
E G
EG
Gutierrez
D000818:Animals; D001812:Blood-Brain Barrier; D006801:Humans; D007276:Injections, Intraventricular; D015850:Interleukin-6 / Q000008:administration & dosage / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics*; D051379:Mice; D011994:Recombinant Proteins / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics; D012044:Regression Analysis
D015850:Interleukin-6; D011994:Recombinant Proteins